berberine has been researched along with fluconazole in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cheng, Y; Geng, RX; Gopala, L; Jeyakkumar, P; Liu, HB; Peng, XM; Zhou, CH | 1 |
| Cai, Z; Chai, X; Ding, Z; Gao, Y; Hao, Y; Jiang, Y; Jin, Y; Li, R; Ni, T; Wang, T; Xie, F; Yu, S; Zhang, D; Zhao, J | 1 |
| Bheemanaboina, RRY; Gao, WW; Gopala, L; Li, S; Zhang, GB; Zhou, CH | 1 |
| Ba, Y; Hou, X; Wang, S; Xu, Z; Yang, H; Zhang, J | 1 |
| Cao, YY; Gao, PH; Jiang, YY; Qin, XF; Quan, H; Xu, Z; Zhao, JX | 1 |
| Dai, BD; Gao, PH; Jiang, YY; Liang, RM; Tang, RJ; Wang, Y; Xu, Y; Yan, L | 1 |
| Endo, EH; Filho, BP; Garcia, LB; Iwazaki, RS; Nakamura, CV; Ueda-Nakamura, T | 1 |
| Hu, DD; Jiang, YY; Li, DD; Li, MB; Mylonakis, E; Quan, H; Wang, Y; Xu, Y; Zhang, DZ; Zhao, LX; Zhu, LH | 1 |
| An, M; Cai, Z; Cao, Y; Chen, S; Dai, L; Jiang, Y; Jiang, Z; Li, Y; Liu, H; Liu, J; Liu, W; Ni, T; Tian, S; Wang, L; Wei, C; Wu, C; Yang, J; Zang, C; Zhang, D; Zhao, M; Zhu, S | 1 |
| Cai, Z; Cao, YB; Gao, Y; Jiang, YY; Ni, TJ; Tan, SL; Tian, SJ; Zang, CX; Zhang, DZ | 1 |
| An, MM; Cao, XJ; Chen, SM; He, LJ; Huang, X; Jiang, YY; Li, LP; Liu, H; Liu, W; Qi, YP; Shen, H; Xu, Z; Yan, L; Zhang, DZ; Zhang, JD; Zhang, SQ; Zhu, F | 1 |
| Campos, Rde S; Cavalcanti, BC; Costa Silva, RA; da Silva, AR; da Silva, CR; de Andrade Neto, JB; de Andrade, LN; de Moraes, MO; do Nascimento, FB; Freitas, DD; Grangeiro, TB; Magalhães, HI; Nobre Júnior, HV; Sampaio, LS | 1 |
| Shao, J; Shi, G; Wang, C; Wang, T; Wu, D | 1 |
| Huang, Z; Liu, W; Ma, K; Shi, P; Wang, Q; Yang, Z | 1 |
| Huang, X; Li, D; Li, Y; Song, Z; Sun, J; Yi, Y; Yong, J | 1 |
| Huang, X; Li, Y; Yong, J; Zheng, D | 1 |
| Alterovitz, G; Bai, F; Calderone, R; Chen, X; Dai, H; Huang, R; Jiang, L; Jiang, Y; Liu, X; Ouyang, L; Pei, G; Pu, Y; Ren, B; Song, F; Sun, N; Tong, Y; Wang, S; Wang, X; Wang, XM; Wei, Q; Xia, X; Xie, N; Zhang, B; Zhang, J; Zhang, L; Zhang, Y; Zhu, G | 1 |
| Gupta, H; Gupta, P; Poluri, KM; Tripathi, S | 1 |
1 review(s) available for berberine and fluconazole
| Article | Year |
|---|---|
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
Topics: Anti-Bacterial Agents; Bacterial Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles | 2019 |
18 other study(ies) available for berberine and fluconazole
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Novel benzimidazolyl tetrahydroprotoberberines: Design, synthesis, antimicrobial evaluation and multi-targeting exploration.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Benzimidazoles; Berberine Alkaloids; Cattle; DNA; Fungi; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses | 2017 |
Design, synthesis, and SAR study of 3-(benzo[d][1,3]dioxol-5-yl)-N-benzylpropanamide as novel potent synergists against fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Benzodioxoles; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Berberine; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2018 |
Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Topics: Antifungal Agents; Berberine; Candida albicans; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2006 |
Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation.
Topics: Adenosine Triphosphate; Antifungal Agents; Antioxidants; Ascorbic Acid; Berberine; Candida albicans; Cell Respiration; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Fungal Proteins; Humans; Membrane Potential, Mitochondrial; Microbial Sensitivity Tests; Proteome; Reactive Oxygen Species | 2009 |
In vitro antifungal activity of the berberine and its synergism with fluconazole.
Topics: Antifungal Agents; Berberine; Candida albicans; Candidiasis; Drug Synergism; Fluconazole; Humans; Microbial Sensitivity Tests | 2010 |
Fluconazole assists berberine to kill fluconazole-resistant Candida albicans.
Topics: Acridine Orange; Antifungal Agents; Benzophenanthridines; Berberine; Biological Transport; Candida albicans; Cell Cycle Checkpoints; Cell Cycle Proteins; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Intercalating Agents; Isoquinolines; Membrane Transport Proteins; Methylene Blue; Microbial Sensitivity Tests | 2013 |
Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans.
Topics: Acetamides; Antifungal Agents; Berberine; Candida albicans; Cell Survival; Dioxoles; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Human Umbilical Vein Endothelial Cells; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship | 2014 |
[Derivatization of berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans].
Topics: Antifungal Agents; Berberine; Candida albicans; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Isoquinolines; Microbial Sensitivity Tests | 2014 |
Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
Topics: Antifungal Agents; Berberine; Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Microbial Sensitivity Tests | 2015 |
Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
Topics: Animals; Antifungal Agents; Berberine; Biofilms; Candida; Candidiasis; Cell Line; Cell Proliferation; Cryptococcosis; Cryptococcus neoformans; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; L Cells; Mice; Microbial Sensitivity Tests; Mitochondrial Membranes; Molecular Typing; Mycological Typing Techniques | 2016 |
Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates.
Topics: Antifungal Agents; Berberine; Biofilms; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; RNA, Messenger | 2017 |
Fluconazole inhibits cellular ergosterol synthesis to confer synergism with berberine against yeast cells.
Topics: Antifungal Agents; Berberine; Cell Membrane Permeability; Drug Synergism; Ergosterol; Fluconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 2018 |
Inhibitory effect of berberine hydrochloride against Candida albicans and the role of the HOG-MAPK pathway.
Topics: Adenosine Triphosphate; Antifungal Agents; Berberine; Candida albicans; Fluconazole; Genes, Fungal; Glucan 1,3-beta-Glucosidase; Glycerol; Hyphae; Microbial Sensitivity Tests; Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Signal Transduction | 2021 |
Antifungal activity and potential mechanism of berberine hydrochloride against fluconazole-resistant
Topics: Antifungal Agents; Berberine; Candida albicans; Drug Resistance, Fungal; Fluconazole; Glycerol; Microbial Sensitivity Tests | 2022 |
Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p.
Topics: Animals; Antifungal Agents; Berberine; Candida albicans; Drug Resistance, Multiple; Fluconazole; Mice | 2021 |
Biochemical and metabolomic insights into antifungal mechanism of berberine against Candida glabrata.
Topics: Antifungal Agents; Berberine; Candida glabrata; Drug Resistance, Fungal; Fluconazole; Metabolomics; Microbial Sensitivity Tests | 2023 |